I'm interested in this biotech which has 7 products in development focused on their own non-invasive alternative-delivery method - a transdermal spray onto the skin for absorption over a 24 hour period. Over the past seven years, they have evolved to the stage where they have partners for four products - including CSL, Vivus, EliLilly and Organon (the latter signed up just last week). They also appear to have an impressive array of industry experience in there management team.
Could be one to watch in these turbulent times - up 5 cents (4.17%) today against the flow!
For their Investor presentation see their Company website: